BIOWKS Bio-Works Technologies AB (publ)

0.2992USD3.040 SEK · STO+4.47%Mkt Cap: 30.24M USDP/E: —

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activa…

Key Statistics

Company
Market Cap30.24M USD
Enterprise Value25.93M USD
Revenue (TTM)8.14M USD
Gross Profit4.71M USD
Net Income (TTM)-1.50M USD
Revenue/Share0.08 USD
Last Price0.2992 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees32
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0007387089
Valuation
P/E (Trailing)—
P/E (Forward)5.02
PEG—
EV/EBITDA-31.70
EV/Revenue3.18
P/S3.71
P/B6.73
EPS (TTM)-0.0049 USD
EPS (Forward)0.06 USD
52W Range
0.209732% of range0.4902
52W High0.4902 USD
52W Low0.2097 USD
Profitability
Gross Margin76.48%
Oper. Margin-10.68%
EBITDA Margin-10.05%
Profit Margin-24.39%
ROE-30.99%
ROA-21.55%
ROIC—
ROCE-36.81%
Growth
Revenue Growth-42.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.85M USD
CapEx (TTM)39.77K USD
FCF Margin1.34%
FCF Yield0.36%
Net Debt-4.31M USD
Net Debt/EBITDA5.27
Net Debt/FCF-39.46
Balance Sheet
Debt/Equity—
Current Ratio2.74
Quick Ratio1.99
Book Value/Sh0.04 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.100.41M
Float46.79M
Insiders50.44%
Institutions11.93%
Technical
SMA 500.3063 (-2.3%)
SMA 2000.3239 (-7.6%)
Beta0.85
S&P 52W Chg12.00%
Avg Vol (30d)41.21K
Avg Vol (10d)46.25K
Technical Indicators
RSI (14)49.2
MACD-0.0348
MACD Signal-0.0345
MACD Hist.-0.0003
BB Upper0.3131 USD
BB Middle0.2991 USD
BB Lower0.2851 USD
BB Width9.37%
ATR (14)0.0208 USD
Vol Ratio (20d)0.01x

About Bio-Works Technologies (STO: BIOWKS)

›

Bio-Works Technologies (STO: BIOWKS) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 32 employees.

The shares were at 3.040 SEK on 18 November 2026, up 10.5% over 52 weeks. Its 52-week range is 2.130 SEK to 4.980 SEK: the price is 39.0% below the high and 42.7% above the low.

Its market capitalisation is 307.27M SEK.

Bio-Works Technologies reports return on equity of -31.0%, an operating margin of -10.7% and revenue down 42.0% year over year.

It holds more cash than debt, a net cash position of 43.81M SEK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.